Search

everythinglearnresearchcommunity

for

Search:↓

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

Steroid sulfatase is important for activating hormones that affect memory, brain function, and certain diseases, and could be a target for treating hormone-related disorders.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Certain drugs increase calcium levels in cancer cells by triggering internal calcium release.

Stereotactic body radiation therapy and radiosurgery are advanced, precise treatments that target tumors while protecting healthy tissue.

Adding a second method to PROTACs could improve cancer treatment.

SGK1 is important in cancer growth and treatment resistance, and targeting it could improve therapies.

CXXC5 can both suppress and promote cancer, making it a complex target for treatment.

Treatment restored normal sexual characteristics and blood condition in a patient with testicular cancer.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

Sex hormones might influence bladder cancer development, and aromatase inhibitors could increase risk in postmenopausal women.

Male genital development is driven by androgen signaling and understanding it could help address congenital anomalies.

Baldness may lower the risk of testicular cancer.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

New compounds with carborane showed anti-androgen effects similar to flutamide.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Androgens like testosterone are important hormones for both men and women, made differently in each sex and affecting the body by regulating genes and quick interactions with cell components.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

Androgens affect many aspects of female health, and more research is needed to understand their roles and treatment potential.

Certain drugs that block specific enzymes can help treat prostate diseases.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Finasteride does not prevent bladder cancer.